OncBiomune is just starting to put themselves on the map. Phase II starting soon in Mass at the Beth Israel Deaconess Medical Center of Harvard Medical School. The investigators are Dr. Rupal Bhatt, Dr. Glenn Bubley and Dr. David Einstein whom I did do a bit of DD on are impressive. I ran out of time on Dr. Einstein though so if you guys have his profile please post it. I will say I think some are actually assigned to these start ups to try and hold them back. But, that's why we do our own DD. Added yesterday. And I'm still a buyer.
News 
Market Data 
Discover 
